Weekly Current Affairs: Week- 3 December 2023 (27 Topics)
1
Dec
2
Dec
4
Dec
5
Dec
6
Dec
7
Dec
8
Dec
9
Dec
11
Dec
12
Dec
13
Dec
14
Dec
15
Dec
16
Dec
18
Dec
19
Dec
20
Dec
21
Dec
22
Dec
23
Dec
25
Dec
26
Dec
27
Dec
28
Dec
29
Dec
30
Dec
COVID sub-variant JN.1
Context
Recently, the Union Health Ministry has announced an alert on the Indian variant of COVID-19, namely JN.1, which was included in thelist of ‘variant of Interest’ by World Health Organisation (WHO).
About
The Rising COVID-19 Cases and JN.1 Sub-Variant:
|
Understanding JN.1 Variant:
|
- Focus: Surge in COVID-19 cases, particularly the JN.1 sub-variant.
- Statistics: India reports 21 cases of JN.1, with 19 traced to Goa, and 1 each in Kerala and Maharashtra.
II. Authorities' Response and Home-based Treatment
- Alert Status: Authorities on high alert; 92% opt for home-based treatment.
- Government Actions: Health Minister's virtual meeting, emphasizing mock drills every three months.
- Statement: No need to panic; preparedness through drills, surveillance, and effective communication.
III. Epidemiological Trends and Deaths in December
- Data Analyst's Insight: 19 COVID-19 deaths in December, conflicting reports of 16 deaths.
- Daily Cases: 614 fresh cases on December 19, the highest since May 20.
- Regional Trends: Kerala reports 2,041 of 2,311 active cases, attributing to robust reporting.
III. WHO Monitoring and Variant of Interest (VOI)
- WHO Classification:1 classified as a VOI; considered a low global public health risk.
- Other VOIs:1.5, XBB.1.16, EG.5, BA.2.86—all descendants of omicron sub-variants.
IV. Understanding Variants of Interest (VOIs)
- Definition: A SARS-CoV-2 variant with genetic changes impacting transmissibility, virulence, etc.
- VOI Criteria: Growth advantage in multiple WHO regions, increasing prevalence over time, and notable epidemiological impacts.
V. Surveillance and Genome Sequencing
- Global Collaboration: Genomic surveillance, epidemiology, and clinical behavior monitoring.
- Submission Requirements: Countries encouraged submitting genome sequences to GISAID and share virus isolates via WHO Biohub.
VI. JN.1 Sequences and International Cooperation
- Data Submission: 7,344 JN.1 sequences from 41 countries on GISAID as of December 16.
- International Contribution: India third-largest contributor to GISAID globally.
Way Forward:
Criteria for VOCs: Must meet VOI criteria and exhibit detrimental changes in severity, impact on health systems, or vaccine effectiveness.
Courses
Study Notes
Home
Resources
More